Name: Samuel S. Lee Address: 3330 Hospital Dr NW Calgary, AB, T2N 4N1 Canada Telephone: (403) 220-8457 Fax: (403) 270-0995 Email: samlee@ucalgary.ca Present Rank: Professor Department: Medicine Faculty: Medicine Institution: University of Calgary Consultant for (past 5 years): Abbvie, Boehringer Ingelheim, Gilead, Healix, London Drugs, Merck, Novartis, Oncoustics (chair of medical advisory board), Pendopharm, and Justice Canada (HCV 1986-90 “Tainted Blood” compensation program) MOST RECENT PUBLICATIONS: 1. Liu H, Alhassan N, Yoon KT, Almutlaq L, Lee SS. Oxidative stress triggers hyperdynamic circulation via central neural activation in portal hypertensive rats. Hepatol Int 2023, Online ahead of print. 2. El-Kassas M, Emadeldeen M, Hassany M, Esmat G, Gomaa AA, El-Raey F, Congly SE, Liu H, Lee SS. A randomized controlled trial of SOF/VEL/VOX with or without ribavirin for retreatment of chronic hepatitis C. J Hepatol. Online ahead of print. 3. Vandenberk B, Altieri MH, Liu H, Raj SR, Lee SS. Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis. Aliment Pharmacol Ther 2023 Feb;57(3):290-303.doi: 10.1111/apt.17368.